Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 10225
Country/Region: Zambia
Year: 2016
Main Partner: Eastern Province Health Office - Zambia
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $4,397,652 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $600,000
Care: TB/HIV (HVTB) $300,000
Care: Pediatric Care and Support (PDCS) $100,000
Laboratory Infrastructure (HLAB) $100,000
Strategic Information (HVSI) $220,000
Health Systems Strengthening (OHSS) $250,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $381,872
Testing: HIV Testing and Counseling (HVCT) $300,000
Sexual Prevention: Other Sexual Prevention (HVOP) $100,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $300,000
Treatment: Adult Treatment (HTXS) $1,445,780
Treatment: Pediatric Treatment (PDTX) $300,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Number of people receiving post-GBV care 2017 2,000
HTS_TST Age/sex: <1 2017 4
HTS_TST Age/sex: 1-9 2017 742
HTS_TST Age/sex: 10-14 Female 2017 1,567
HTS_TST Age/sex: 10-14 Male 2017 1,533
HTS_TST Age/sex: 15-19 Female 2017 5,037
HTS_TST Age/sex: 15-19 Male 2017 3,896
HTS_TST Age/sex: 20-24 Female 2017 8,634
HTS_TST Age/sex: 20-24 Male 2017 5,407
HTS_TST Age/sex: 25-49 Female 2017 10,840
HTS_TST Age/sex: 25-49 Male 2017 6,452
HTS_TST Age/sex: 50+ Female 2017 1,712
HTS_TST Age/sex: 50+ Male 2017 1,277
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 2,289
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,959
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 25,383
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 17,470
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 47,101
HTS_TST Service Delivery Point (Facility): Index testing 2017 302
HTS_TST Service Delivery Point (Facility): Inpatient 2017 6,408
HTS_TST Service Delivery Point (Facility): Malnutrition facilities 2017 5
HTS_TST Service Delivery Point (Facility): Other PITC 2017 6,295
HTS_TST Service Delivery Point (Facility): Outpatient 2017 22,880
HTS_TST Service Delivery Point (Facility): Pediatric 2017 1,576
HTS_TST Service Delivery Point (Facility): PMTCT 2017 2,481
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 914
HTS_TST Service Delivery Point (Facility): VCT 2017 6,082
HTS_TST Service Delivery Point (Facility): VMMC 2017 158
HTS_TST Sum of Age/Sex disaggregates 2017 46,355
HTS_TST Sum of Aggregated Age/Sex <15 2017 4,248
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 42,853
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 47,101
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 102
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 103
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 233
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 120
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 365
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 274
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 715
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 398
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 120
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 88
HTS_TST_POS Test Result by Age: Positive: <1 2017 2
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 32
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 136
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 115
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,479
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 822
PMTCT_ART Already on ART at beginning of current pregnancy 2017 282
PMTCT_ART New on ART 2017 196
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 21,949
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 318
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 260
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 4
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 6
PMTCT_EID Sum of Infant Age disaggregates 2017 578
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 126
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 4,111
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 9,157
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 8,555
PMTCT_STAT By: Known positives at entry 2017 1,083
PMTCT_STAT By: Number of new positives identified 2017 578
PMTCT_STAT Number of new ANC and L&D clients 2017 21,949
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 21,949
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 8
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 203
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 320
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 556
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: <15 2017 7
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 70
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 211
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 286
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,661
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 126
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 4,111
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 9,157
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 8,555
PP_PREV Aggregated Age/sex: <15 Female 2017 983
PP_PREV Aggregated Age/sex: <15 Male 2017 837
PP_PREV Aggregated Age/sex: 15+ Female 2017 1,461
PP_PREV Aggregated Age/sex: 15+ Male 2017 1,028
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 4,309
PP_PREV Total number of people in the target population 2017 4,309
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 22
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 648
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 16
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 465
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 1,151
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,151
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 2,598
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 124
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 1,254
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,220
TB_SCREENDX Screen Result: Screened Positive for TB 2017 2,598
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 26,629
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 17,704
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 2,330
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 1,917
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 48,580
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 20
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 207
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 31
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 208
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 466
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 466
TX_CURR Age/Sex: <1-9 2017 428
TX_CURR Age/Sex: 10-14 Female 2017 2,253
TX_CURR Age/Sex: 10-14 Male 2017 1,948
TX_CURR Age/Sex: 15-19 Female 2017 4,306
TX_CURR Age/Sex: 15-19 Male 2017 2,294
TX_CURR Age/Sex: 20-24 Female 2017 10,305
TX_CURR Age/Sex: 20-24 Male 2017 6,120
TX_CURR Age/Sex: 25-49 Female 2017 11,193
TX_CURR Age/Sex: 25-49 Male 2017 9,010
TX_CURR Age/Sex: 50+ Female 2017 1,128
TX_CURR Age/Sex: 50+ Male 2017 690
TX_CURR Aggregated Age/Sex: <15 Female 2017 2,623
TX_CURR Aggregated Age/Sex: <15 Male 2017 2,006
TX_CURR Aggregated Age/Sex: 15+ Female 2017 27,544
TX_CURR Aggregated Age/Sex: 15+ Male 2017 17,502
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 49,675
TX_CURR Sum of age/sex disaggregates 2017 6,600
TX_CURR Sum of Aggregated Age/Sex <15 2017 4,629
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 45,046
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 49,675
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 236
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 162
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 2,504
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,697
TX_NEW By Age/Sex: 1-9 2017 46
TX_NEW By Age/Sex: 10-14 Female 2017 195
TX_NEW By Age/Sex: 10-14 Male 2017 153
TX_NEW By Age/Sex: 15-19 Female 2017 398
TX_NEW By Age/Sex: 15-19 Male 2017 257
TX_NEW By Age/Sex: 20-24 Female 2017 762
TX_NEW By Age/Sex: 20-24 Male 2017 468
TX_NEW By Age/Sex: 25-49 Female 2017 1,079
TX_NEW By Age/Sex: 25-49 Male 2017 728
TX_NEW By Age/Sex: 50+ Female 2017 265
TX_NEW By Age/Sex: 50+ Male 2017 248
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 4,599
TX_NEW Sum of Age/Sex disaggregates 2017 4,553
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 4,599
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 15,715
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 15,715
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 1,094
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 817
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 8,483
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 5,321
TX_PVLS Numerator: Indication: Routine 2017 13,156
TX_PVLS Numerator: Indication: Targeted 2017 2,559
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 1,065
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 649
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 8,669
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 5,332
TX_PVLS_den Denominator: Indication: Routine 2017 13,156
TX_PVLS_den Denominator: Indication: Targeted 2017 2,559
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 159
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 215
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 134
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 627
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 428
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 839
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 553
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,327
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 908
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 227
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 119
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 341
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 284
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,024
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,887
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 5,536
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 5,536
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 159
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 215
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 134
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 627
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 428
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 839
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 553
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,327
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 908
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 227
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 119
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 431
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 357
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,934
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,814
VMMC_CIRC By Age: 10-14 2017 234
VMMC_CIRC By Age: 15-19 2017 564
VMMC_CIRC By Age: 20-24 2017 3,321
VMMC_CIRC By Age: 25-29 2017 2,724
VMMC_CIRC By Age: 30-49 2017 909
VMMC_CIRC By Age: 50+ 2017 69
VMMC_CIRC By circumcision technique: Device-based VMMC 2017 253
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 7,568
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 7,821
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 7,821
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 4,188
Cross Cutting Budget Categories and Known Amounts Total: $50,719
Food and Nutrition: Policy, Tools, and Service Delivery $50,719